EXTENDED SPECTRUM Β- LACTAMASE PRODUCING SHIGELLA FLEXNERIA CASE REPORT

ESBL Producing Shigella Flexneri

Authors

  • Mehreen Gilani Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Tehmina MunirMunir Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Mahwish Latif Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Amira Haroon Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Sabahat Rehman Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan

Abstract

Infection by Shigella species is one of the major cause of morbidity especially in children with diarrhea. Extended spectrum β lactamases (ESBL) confer resistance to most of the beta-lactam antibiotics, including penicillins, cephalosporins and aztreonam. Its production in Shigellae is of concern especially in children, in whom treatment options are already limited. Third generation cephalosporins are used for treating diarrhea due to multidrug resistant Shigella species in children, but ESBL production renders them ineffective too. We report an extended spectrum β lactamase producing Shigella flexneri, isolated from the stool sample of a 3-year-old boy.

 

Downloads

Download data is not yet available.

Downloads

Published

31-10-2016

Issue

Vol. 66 No. 5 (2016): October

Section

Case Reports

How to Cite

1.
Gilani M, MunirMunir T, Latif M, Haroon A, Rehman S. EXTENDED SPECTRUM Β- LACTAMASE PRODUCING SHIGELLA FLEXNERIA CASE REPORT: ESBL Producing Shigella Flexneri. Pak Armed Forces Med J [Internet]. 2016 Oct. 31 [cited 2024 Nov. 29];66(5):767-69. Available from: https://pafmj.org/PAFMJ/article/view/893